RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES

BROOKS BR SANJAK M MITSUMOTO H SZIRONY K NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J CEDARBAUM JM CHARATAN M STAMBLER N WITTES J BRITTAIN E

Br. Brooks et al., RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES, Neurology, 43(4), 1993, pp. 416-416

NO

Neurology → ACNP

00283878

43

4

1993

2

416 - 416

ISI

0028-3878(1993)43:4<416:RHCNF(>2.0.ZU;2-3